Skip to main content
INAB
NASDAQ Life Sciences

Significant Shareholder Reduces Stake by $1.35M via Charitable Transfer

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$1.863
Mkt Cap
$18.414M
52W Low
$1.17
52W High
$5.61
52W Position info
59% above low
Off High info
67% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

INAB sits 59% above its 52-week low of $1.17.

Summary

Significant shareholders Malcom and Emily Fairbairn reduced their stake in IN8BIO by transferring 724,637 shares, valued at $1.35 million, to a charitable foundation, bringing their beneficial ownership below 5%.


Key Events · Ownership and Investor Activity · INAB

  • Major Share Disposition

    The Malcom and Emily Fairbairn 2010 CRUT transferred 724,637 shares of common stock to a charitable foundation for no consideration.

  • Reduced Beneficial Ownership

    This disposition, valued at approximately $1.35 million, caused the Fairbairns to cease being beneficial owners of more than five percent of IN8BIO's common stock, significantly reducing their stake.

  • Context of Financial Distress

    This reduction in a significant shareholder's stake comes as IN8BIO faces "going concern" warnings and is actively pursuing capital raises, potentially signaling reduced confidence.


Analysis · INAB · Life Sciences

Malcom and Emily Fairbairn, through their CRUT, transferred 724,637 shares, valued at approximately $1.35 million, to a charitable foundation. This disposition represents a substantial portion of IN8BIO's outstanding shares and results in the Fairbairns ceasing to be beneficial owners of more than five percent of the company's common stock. This reduction in a significant shareholder's stake occurs while the company faces "going concern" warnings and is actively seeking to raise capital, which could be interpreted as a lack of conviction.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, INAB was trading at $1.86 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $18.4M. The 52-week trading range was $1.17 to $5.61. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

INAB - Latest Insights

INAB
Nov 16, 2026, 8:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.820
Real-time Price: $0.8749 info
Change: +$0.0549 (+7%) info
Market Cap: $9.398M info
INAB
Nov 05, 2026, 4:15 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.840
Real-time Price: $0.8749 info
Change: +$0.0349 (+4%) info
Market Cap: $9.398M info
INAB
Aug 06, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.9888
Real-time Price: $0.8749 info
Change: -$0.1139 (-12%) info
Market Cap: $9.398M info
INAB
Jul 09, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.39
Real-time Price: $0.8749 info
Change: -$0.5151 (-37%) info
Market Cap: $9.398M info
INAB
Jun 01, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $1.93
Real-time Price: $0.8749 info
Change: -$1.06 (-55%) info
Market Cap: $9.398M info